Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging

Imaging mitochondrial redox potential and its possible link to tumor metastatic potential

(2012) Lin Z. Li   JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer

(2010) S. Y. Park et al.   CLINICAL CANCER RESEARCH

PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase

(2010) C. Bartholomeusz et al.   CLINICAL CANCER RESEARCH

Quantitative mitochondrial redox imaging of breast cancer metastatic potential

(2010) He N. Xu et al.   JOURNAL OF BIOMEDICAL OPTICS

Metabolic Enzymes as Oncogenes or Tumor Suppressors

(2009) Craig B. Thompson   NEW ENGLAND JOURNAL OF MEDICINE

Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential

(2009) L. Z. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition

(2008) Frank Köster et al.   BREAST CANCER RESEARCH AND TREATMENT

Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution

(2008) D. C. Allred et al.   CLINICAL CANCER RESEARCH